C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 5/08 (2006.01) A61K 38/06 (2006.01)
Patent
CA 2536570
The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers or racemates of said compound, or pharmaceutically acceptable salts or solvates of said compound, said compound having the general structure shown in Formula (1): useful in the treatment or prevention or amelioration of one or more symptoms of hepatitis C.
L'invention porte sur un composé, ou des énantiomères, des stéréoisomères, des rotamères, des tautomères, des racémates, ou un promédicament dudit composé, ou des sels ou des solvants pharmaceutiquement acceptables du composé, ou du promédicaments, Ce composé possède la structure générale représentée dans la formule 1, et est utile dans le traitement ou la prévention, ou l'amélioration d'au moins un symptôme de l'hépatite C.
Chen Kevin X.
Girijavallabhan Viyyoor M.
Njoroge F. George
Velazquez Francisco
Venkatraman Srikanth
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Novel peptidomimetic ns3-serine protease inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel peptidomimetic ns3-serine protease inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel peptidomimetic ns3-serine protease inhibitors of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1928859